DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Chenodeoxycholic acid

Chenodeoxycholic acid

  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1

    PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1

  • |||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka Et Al

    |||||||||||||III US005202354A United States Patent (19) (11) Patent Number: 5,202,354 Matsuoka Et Al

  • Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

    Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes

  • Biliary Bile Acid Composition of the Human Fetus in Early Gestation

    Biliary Bile Acid Composition of the Human Fetus in Early Gestation

  • TRANSPARENCY COMMITTEE Opinion 19 February 2014

    TRANSPARENCY COMMITTEE Opinion 19 February 2014

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • FXR Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux

    FXR Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux

  • Cholic Acid and Chenodeoxycholic Acid for Treating Inborn Errors of Bile Acid Synthesis (All Ages)

    Cholic Acid and Chenodeoxycholic Acid for Treating Inborn Errors of Bile Acid Synthesis (All Ages)

  • The Influence of Bile Acids Homeostasis by Cryptotanshinone-Containing Herbs

    The Influence of Bile Acids Homeostasis by Cryptotanshinone-Containing Herbs

  • EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices

    EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices

  • 2016 Medicines in Development for Rare Diseases a LIST of ORPHAN DRUGS in the PIPELINE

    2016 Medicines in Development for Rare Diseases a LIST of ORPHAN DRUGS in the PIPELINE

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity

    Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity

  • Clinical Aspects of Liver Diseases 40 Treatment of Liver Diseases

    Clinical Aspects of Liver Diseases 40 Treatment of Liver Diseases

  • Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis Via Modulating Bile Acids and Meta-Inflammation S

    Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis Via Modulating Bile Acids and Meta-Inflammation S

  • I (Acts Whose Publication Is Obligatory) COMMISSION

    I (Acts Whose Publication Is Obligatory) COMMISSION

  • OCALIVA, INN-Obeticholic Acid

    OCALIVA, INN-Obeticholic Acid

Top View
  • Chenodeoxycholic Acid Plus Cholic Acid Gut: First Published As 10.1136/Gut.38.4.623 on 1 April 1996
  • Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1Α Protein and Its Target Genes
  • 207999Orig1s000
  • Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells
  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
  • Chenodeoxycholic Acid-Mediated Activation of the Farnesoid X Receptor Negatively Regulates Hydroxysteroid Sulfotransferase
  • Infrared Reference Spectra
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0184245 A1 Eberting (43) Pub
  • Obeticholic Acid: First Global Approval
  • Public Assessment Report
  • Marrakesh Agreement Establishing the World Trade Organization
  • Future Medical Treatment of PSC
  • Glycyrrhizin Alleviates Non-Alcoholic Steatohepatitis Via Modulating Bile Acids and Meta
  • Gastrointestinal Drug Advisory Committee (GIDAC) Meeting
  • Treatment with Milk Thistle Extract (Silybum Marianum
  • Customs Tariff - Schedule
  • Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: a Coordinated Detoxification System with Impact on Health and Diseases
  • Treatment Options for Alcoholic and Non-Alcoholic Fatty Liver Disease: a Review


© 2024 Docslib.org    Feedback